pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
TRP-601
Hypoxic-Ischemic Encephalopathy
Chiesi Farmaceutici SpA
0
catalysts
TRUXIMA
TRUXIMA (RITUXIMAB-ABBS)
Celltrion Inc
0
catalysts
Phase 1
TRV-045
Diabetic Neuropathic Pain
Trevena Inc
0
catalysts
Phase 2
TRX-103
Crohn's Disease (Regional Enteritis)
Tr1X Inc
catalysts
← prev
page 142 of 231
next →
131
Pain
89
Neurology
1
0
Preclinical
TRX-105
Colitis
TaiRx Inc
0
catalysts
Phase 2
TRX-319
Primary Progressive Multiple Sclerosis (PPMS)
Tr1X Inc
0
catalysts
Phase 1
TRX-920
Unspecified Cancer
TaiRx Inc
0
catalysts
Phase 2
TSC-100
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$TCRX
TScan Therapeutics, Inc.
0
catalysts
Phase 2
TSC-101
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$TCRX
TScan Therapeutics, Inc.
0
catalysts
Phase 1
TSC-203 HLA-A*02:01
Head And Neck Cancer
$TCRX
TScan Therapeutics, Inc.
0
catalysts
Phase 1
TSN-084
Triple-Negative Breast Cancer (TNBC)
Tyligand Biotechnology (Shanghai) Co Ltd
0
catalysts
Phase 2
TSN-1611
Solid Tumor
Tyligand Biotechnology (Shanghai) Co Ltd
0
catalysts
Phase 3
TSND-201
Post-Traumatic Stress Disorder (PTSD)
Transcend Therapeutics Inc
0
catalysts
Phase 2
TSRA-196
Alpha-1 Antitrypsin Deficiency (A1AD)
Tessera Therapeutics Inc
0
catalysts
Phase 2
TST-003
Metastatic Colorectal Cancer
Transcenta Holding Ltd
0
catalysts
Phase 1
TST-004
IgA Nephropathy (Berger's Disease)
Transcenta Holding Ltd
0
catalysts
Preclinical
TT-003
Hearing Disorders
Ting Therapeutics LLC
0
catalysts
Phase 1
TT-00920
Congestive Heart Failure (Heart Failure)
TransThera Sciences (Nanjing) Inc
0
catalysts
Phase 1
TT-01488
Diffuse Large B-Cell Lymphoma
TransThera Sciences (Nanjing) Inc
0
catalysts
Phase 1
TT-125
Non-Small Cell Lung Cancer
TOLREMO Therapeutics AG
0
catalysts
Preclinical
TT-20
Unspecified Neurologic Disorders
Tellus Therapeutics Inc
0
catalysts
Phase 3
TTAX-01
Diabetic Foot Ulcers
BioTissue Inc
0
catalysts
Phase 2
TTAX-03
Osteoarthritis Pain
BioTissue Inc
0
catalysts
Phase 1
TTC-352
Metastatic Breast Cancer
TTC Oncology LLC
0
catalysts
Phase 2
TTHX-1114
Fuchs Endothelial Corneal Dystrophy (FECD)
Trefoil Therapeutics LLC
0
catalysts
Phase 2
TTI-101
Metastatic Hepatocellular Carcinoma (HCC)
$TVRD
Tvardi Therapeutics, Inc.
0
catalysts
Phase 1
TTI-109
Fibrosis
$TVRD
Tvardi Therapeutics, Inc.
0
catalysts
Phase 2
TTP-273
Type 2 Diabetes
$VTVT
vTv Therapeutics Inc.
0
catalysts
Phase 1
TTX-080
Acral Lentiginous Melanoma
Tizona Therapeutics Inc
0
catalysts
Phase 2
TTX-181
Batten Disease
Tern Therapeutics LLC
0
catalysts
